Upgrade to SI Premium - Free Trial

Telix Pharmaceuticals (TLX)

9.54 +0.77 (8.78%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/20/26)

Latest Headlines

Telix and United Imaging form theranostics collaboration June 2, 2026 7:01 AM - StreetInsider Telix and United Imaging Announce Strategic Theranostics Collaboration June 2, 2026 7:00 AM - Globe NewsWire Telix presents prostate cancer trial data showing acceptable safety June 1, 2026 5:00 PM - StreetInsider ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026 June 1, 2026 5:00 PM - Globe NewsWire JPMorgan Starts Telix Pharmaceuticals Ltd (TLX:AU) (TLX) at Overweight June 1, 2026 12:55 AM - StreetInsider Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences May 27, 2026 7:00 AM - Globe NewsWire Form 6-K Telix Pharmaceuticals For: May 20 May 21, 2026 4:11 PM - SEC Filing Form 3 Telix Pharmaceuticals For: May 11 Filed by: GILL DAVID N May 18, 2026 6:34 PM - SEC Filing Form 3 Telix Pharmaceuticals For: May 11 Filed by: Jellison William R May 18, 2026 6:33 PM - SEC Filing Form 3 Telix Pharmaceuticals For: May 11 Filed by: Rivas Maria May 18, 2026 6:32 PM - SEC Filing Telix completes enrollment for first-line glioblastoma study May 18, 2026 5:00 PM - StreetInsider IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing May 18, 2026 5:00 PM - Globe NewsWire Telix partners with EDAP and Profound on prostate imaging tech May 15, 2026 6:31 AM - StreetInsider Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches May 15, 2026 6:30 AM - Globe NewsWire Form 4 Telix Pharmaceuticals For: Apr 28 Filed by: Behrenbruch Christian May 6, 2026 9:32 PM - SEC Filing Telix study shows cancer imaging drug may detect broader kidney tumors May 4, 2026 5:01 PM - StreetInsider New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC May 4, 2026 5:00 PM - Globe NewsWire TLX101-Px (Pixlumi®) MAA Accepted in Europe April 30, 2026 5:43 PM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX) April 30, 2026 6:53 AM - StreetInsider Telix presents dosimetry data for prostate cancer drug candidate April 29, 2026 5:01 PM - StreetInsider OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer April 29, 2026 5:00 PM - Globe NewsWire Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach April 27, 2026 7:27 PM - Globe NewsWire Form 6-K Telix Pharmaceuticals For: Apr 22 April 23, 2026 6:05 AM - SEC Filing Telix prostate cancer therapy data to be presented at ASCO 2026 April 21, 2026 4:49 PM - StreetInsider ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026 April 21, 2026 4:49 PM - Globe NewsWire Form 6-K Telix Pharmaceuticals For: Apr 20 April 21, 2026 4:06 PM - SEC Filing Form 6-K Telix Pharmaceuticals For: Apr 19 April 20, 2026 4:29 PM - SEC Filing Telix doses first patient in phase 3 brain cancer therapy trial April 14, 2026 7:05 PM - StreetInsider Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma April 14, 2026 7:04 PM - Globe NewsWire Form 6-K Telix Pharmaceuticals For: Apr 14 April 14, 2026 9:31 AM - SEC Filing Form 6-K Telix Pharmaceuticals For: Apr 14 April 14, 2026 6:04 AM - SEC Filing Form 6-K Telix Pharmaceuticals For: Apr 12 April 13, 2026 4:02 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX) April 13, 2026 6:38 AM - StreetInsider Regeneron and Telix form $2.1 billion radiopharmaceutical partnership April 13, 2026 6:31 AM - StreetInsider Regeneron and Telix Announce Strategic Radiopharma Collaboration April 13, 2026 6:30 AM - Globe NewsWire Telix and Regeneron Announce Strategic Radiopharma Collaboration April 13, 2026 6:30 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX) April 10, 2026 6:45 AM - StreetInsider Form 6-K Telix Pharmaceuticals For: Apr 09 April 10, 2026 6:03 AM - SEC Filing FDA accepts Telix brain cancer imaging drug application April 10, 2026 5:30 AM - StreetInsider FDA Accepts NDA for TLX101-Px (Pixclara®) April 9, 2026 6:51 PM - Globe NewsWire Form 6-K Telix Pharmaceuticals For: Apr 09 April 9, 2026 6:06 AM - SEC Filing Telix adds two non-executive directors to board April 9, 2026 3:57 AM - StreetInsider Telix Strengthens Board with Additional Director Appointments April 8, 2026 6:44 PM - Globe NewsWire Telix Pharmaceuticals Ltd (TLX:AU) (TLX) PT Raised to AUD30 at Canaccord April 8, 2026 3:08 AM - StreetInsider Form 6-K Telix Pharmaceuticals For: Mar 31 April 7, 2026 12:42 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX) April 7, 2026 7:46 AM - StreetInsider Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement April 6, 2026 7:39 PM - Globe NewsWire Form 6-K Telix Pharmaceuticals For: Apr 01 April 2, 2026 4:04 PM - SEC Filing Telix Appoints David Gill as Non-Executive Director April 1, 2026 7:53 PM - Globe NewsWire Form 4 Telix Pharmaceuticals For: Mar 29 Filed by: Smith Darren Charlton April 1, 2026 7:15 PM - SEC Filing Form 3 Telix Pharmaceuticals For: Mar 18 Filed by: Cade David Norman April 1, 2026 7:25 AM - SEC Filing Form 3 Telix Pharmaceuticals For: Mar 18 Filed by: Smith Darren Charlton April 1, 2026 7:25 AM - SEC Filing Form 3 Telix Pharmaceuticals For: Mar 18 Filed by: Nelson Mark Alexander April 1, 2026 7:25 AM - SEC Filing Form 3 Telix Pharmaceuticals For: Mar 18 Filed by: Patti Darren Joel April 1, 2026 7:24 AM - SEC Filing William Blair Shuffles Analyst Conviction List for April 2026 April 1, 2026 7:15 AM - StreetInsider Form 20-F/A Telix Pharmaceuticals For: Dec 31 March 20, 2026 4:07 PM - SEC Filing Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S. March 20, 2026 2:00 AM - StreetInsider Form 3 Telix Pharmaceuticals For: Mar 18 Filed by: McDonald Marie Elizabeth March 18, 2026 8:49 PM - SEC Filing Form 3 Telix Pharmaceuticals For: Mar 18 Filed by: Skinner Jann Elizabeth March 18, 2026 8:47 PM - SEC Filing Form 3 Telix Pharmaceuticals For: Mar 18 Filed by: Behrenbruch Christian March 18, 2026 8:46 PM - SEC Filing Form 6-K Telix Pharmaceuticals For: Mar 15 March 16, 2026 5:01 PM - SEC Filing Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate March 15, 2026 5:25 PM - Globe NewsWire Form 6-K Telix Pharmaceuticals For: Mar 09 March 10, 2026 4:58 PM - SEC Filing Telix reports positive Phase 3 Part 1 results for prostate cancer drug March 9, 2026 7:20 PM - StreetInsider ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives March 9, 2026 7:20 PM - Globe NewsWire Full Article List